Logo image
Pre-existing influenza antibodies, younger age, and increased CD4 TE+EM predict influenza vaccination responses in transplant recipients
Journal article   Open access   Peer reviewed

Pre-existing influenza antibodies, younger age, and increased CD4 TE+EM predict influenza vaccination responses in transplant recipients

Christiane Rollenhagen, Gomathy Parvathinathan, Margaret R. Stedman, Geetha Chalasani, Kelly A. Birdwell, M.Lee Sanders, Mohan Ramkumar, Lauren E. Higdon, Naiqing Ye, Jefferson J.S. Santos, …
Human immunology, Vol.87(5), 111721
05/2026
DOI: 10.1016/j.humimm.2026.111721
PMID: 41812549
url
https://doi.org/10.1016/j.humimm.2026.111721View
Published (Version of record) Open Access

Abstract

Recipients of kidney transplants require lifelong immunosuppression therapy which is associated with a reduced response to vaccinations. We conducted a longitudinal study of influenza vaccination in US Veteran kidney transplant recipients and correlated demographic factors and T cell characteristics to the immunological outcome of the vaccination. Our data suggest that a consistent history of annual vaccination during the 3 years prior is linked to an increase in influenza antibodies prior to vaccination. High influenza titers post-vaccination are associated with younger age, increased CD4 TE+EM cells and pre-existing anti-influenza IgG levels but no association of CMV serostatus or immunologically aged T cells was detected. Thus, preexisting IgG antibodies, age, and CD4 TE+EM cells could serve as predictors for the successful influenza vaccination in this at-risk population informing targeted interventions to improve vaccine responses, prevent infections, and reduce influenza-associated comorbidities.
Influenza Kidney Transplant Vaccination

Details

Metrics

1 Record Views
Logo image